Quinishal is indicated mainly in the uncomplicated strains of P. falciparum malaria. Consideration must be given to the WHO guidelines and to local health authorities
Quinishal is indicated mainly in the uncomplicated strains of P. falciparum malaria. Consideration must be given to the WHO guidelines and to local health authorities recommendations based on the prevalence of resistance to antimalarial agents.
Quinine and its salts are contra-indicated in patients with a history of hypersensitivity to quinine and in patients with tinnitus or optic neuritis and especially when this takes the form of cutaneous, angioedematous, visual, or auditory symptoms. Quinine should be discontinued immediately if evidence of haemolysis appears. As quinine has been implicated in precipitating blackwater fever, it is generally contraindicated in patients who have already suffered an attack. Quinine should be avoided in patients with myasthenia gravis, as it may aggravate their condition.>
About Shalina Healthcare
Shalina Healthcare is a market leader in making quality healthcare products affordable and available across Africa.
We achieve this by sourcing from WHO-approved production facilities in India and China and by focusing on our first-class distribution expertise.
Challenges & Features
© 2023 Shalina Healthcare. All Rights Reserved